ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

Coordinated budget For Federal R&D Urged In NAS Report

January 12, 1996

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

CTAC Discussion, Group Chairs Comment

December 17, 2010

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992